Let’s reconsider modern progestin-only pills during isotretinoin and retinoid therapy

References

• Nelson AM, Gilliland KL, Cong Z, et al. 13-cis retinoic acid induces apoptosis and cell cycle arrest in human SEB-1 sebocytes. J Invest Dermatol. 2006;126(10):2178–2189. doi: 10.1038/sj.jid.5700289.
   PubMed Web of Science ®Google Scholar
• Khalil S, Bardawil T, Stephan C, et al. Retinoids: a journey from the molecular structures and mechanisms of action to clinical uses in dermatology and adverse effects. J Dermatolog Treat. 2017;28(8):684–696. doi: 10.1080/09546634.2017.1309349.
   PubMed Web of Science ®Google Scholar
• Plewig G, Schill WB, Hofmann C. Oral treatment with tretinoin: andrological, trichological, ophthalmological findings and effects on acne (author’s transl). Arch Dermatol Res. 1979;265(1):37–47. doi: 10.1007/BF00412699.
   PubMed Web of Science ®Google Scholar
• Merker H, Stüttgen G. Oral vitamin A acid therapy. Acta Derm Venereol Suppl (Stockh). 1975;74:64–72.
   PubMedGoogle Scholar
• Peck GL, Olsen TG, Yoder FW, et al. Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. N Engl J Med. 1979;300(7):329–333. doi: 10.1056/NEJM197902153000701.
   PubMed Web of Science ®Google Scholar
• Layton A. The use of isotretinoin in acne. Dermatoendocrinol. 2009;1(3):162–169. doi: 10.4161/derm.1.3.9364.
   PubMedGoogle Scholar
• Landis MN. Optimizing isotretinoin treatment of acne: update on current recommendations for monitoring, dosing, safety, adverse effects, compliance, and outcomes. Am J Clin Dermatol. 2020;21(3):411–419. doi: 10.1007/s40257-020-00508-0.
   PubMed Web of Science ®Google Scholar
• Manfredini M, Bettoli V, Forconi R, et al. Creatine phosphokinase values during low starting dose isotretinoin therapy. Skin Appendage Disord. 2020;6(3):142–146. doi: 10.1159/000507455.
   PubMed Web of Science ®Google Scholar
• Khiali S, Gharekhani A, Entezari-Maleki T. Isotretinoin; A review on the utilization pattern in pregnancy. Adv Pharm Bull. 2018;8(3):377–382. doi: 10.15171/apb.2018.044.
   PubMedGoogle Scholar
• Draghici C-C, Miulescu R-G, Petca R-C, et al. Teratogenic effect of isotretinoin in both fertile females and males (review). Exp Ther Med. 2021;21(5):534. doi: 10.3892/etm.2021.9966.
   PubMed Web of Science ®Google Scholar
• Simin MK, Nagesh M. Pregnancy prevention programs for medications used in dermatology. JSSTD. 2020;2:18–25. doi: 10.25259/JSSTD_49_2019.
   Google Scholar
• Am L, D B, Hp G, et al. A review of the european directive for prescribing systemic isotretinoin for acne vulgaris. J Europ Acad Dermatol Venereol JEADV. 2006;20(7):773–776. https://pubmed.ncbi.nlm.nih.gov/16898895/
   PubMed Web of Science ®Google Scholar
• Durán CE, Riera-Arnau J, Abtahi S, et al. Impact of the 2018 revised pregnancy prevention programme by the european medicines agency on the use of oral retinoids in females of childbearing age in Denmark, Italy, Netherlands, and Spain: an interrupted time series analysis. Front Pharmacol. 2023;14:1207976. doi: 10.3389/fphar.2023.1207976.
   PubMed Web of Science ®Google Scholar
• iPLEDGE REMS. Home. https://ipledgeprogram.com/#Main
   Google Scholar
• Hendrix CW, Jackson KA, Whitmore E, et al. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther. 2004;75(5):464–475. doi: 10.1016/j.clpt.2004.01.003.
   PubMed Web of Science ®Google Scholar
• Berbis P, Bun H, Geiger JM, et al. Acitretin (RO10-1670) and oral contraceptives: interaction study. Arch Dermatol Res. 1988;280(6):388–389. doi: 10.1007/BF00426620.
   PubMed Web of Science ®Google Scholar
• Kovacs G. Progestogen-only pills and bleeding disturbances. Hum Reprod. 1996;11(Suppl 2):20–23. doi: 10.1093/humrep/11.suppl_2.20.
   PubMedGoogle Scholar
• McCann MF, Potter LS. Progestin-only oral contraception: a comprehensive review. Contraception. 1994;50(6):S9–S13. doi: 10.1016/0010-7824(94)90120-1.
   Web of Science ®Google Scholar
• Benagiano G, Primiero FM. Seventy-five microgram desogestrel minipill, a new perspective in estrogen-free contraception. Ann N Y Acad Sci. 2003;997(1):163–173. doi: 10.1196/annals.1290.019.
   PubMedGoogle Scholar
• Kubba A, Gemzell-Danielsson K, Palacios S, et al. The drospirenone (DRSP)-only pill: clinical implications in the daily use. Eur J Contracept Reprod Health Care. 2023;28(1):36–43. doi: 10.1080/13625187.2022.2164186.
   PubMed Web of Science ®Google Scholar
• Chiara Del Savio M, De Fata R, Facchinetti F, et al. Drospirenone 4 mg-only pill (DOP) in 24 + 4 regimen: a new option for oral contraception. Expert Rev Clin Pharmacol. 2020;13(7):685–694. doi: 10.1080/17512433.2020.1783247.
   PubMed Web of Science ®Google Scholar
• Lazorwitz A, Davis A, Swartz M, et al. The effect of carbamazepine on etonogestrel concentrations in contraceptive implant users. Contraception. 2017;95(6):571–577. doi: 10.1016/j.contraception.2017.03.004.
   PubMed Web of Science ®Google Scholar
• Lazorwitz A, Pena M, Sheeder J, et al. Effect of topiramate on serum etonogestrel concentrations Among contraceptive implant users. Obstet Gynecol. 2022;139(4):579–587. doi: 10.1097/AOG.0000000000004697.
   PubMed Web of Science ®Google Scholar
• Lazorwitz A, Seale R, Davis A, et al. A pilot study on the effect of isotretinoin on serum etonogestrel concentrations in contraceptive implant users. Contraception. 2020;102(1):58–60. doi: 10.1016/j.contraception.2020.04.011.
   PubMed Web of Science ®Google Scholar